Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Provigil

Chantix Among Drugs Being Reviewed by FDA

Jun 5, 2009
| Parker Waichman LLP
The anti-smoking drug Chantix is among 20 medications currently undergoing a  Food & Drug Administration (FDA) safety review. ...

Study: Provigil Might Be Addictive

Mar 19, 2009
| Parker Waichman LLP
Narcolepsy drug Provigil has been found to have potential links to addiction, according to recent U.S. study conducted by drug abuse experts,...

Cephalon to Pay $425 Million to Settle Illegal Marketing Charges Involving Actiq, Provigil and Gabitril

Sep 30, 2008
| Parker Waichman LLP
Cephalon Inc. has reached a settlement with federal prosecutors over charges that the drug maker illegally marketed its narcotic painkiller Actiq, as...

Provigil Needs Stronger Warning Against Use In Children, FDA Panel Says

Nov 29, 2007
| Parker Waichman LLP
Provigil, a drug used to treat excessive sleepiness, should bear a stronger warning on its label that the medication is not approved for use in...

Provigil Warnings Added For Serious Skin Rashes, Psychiatric Problems

Oct 25, 2007
| Parker Waichman LLP
The Provigil label has been updated to include warnings about life-threatening skin rashes and psychiatric problems linked to the drug.  The...

Page 1/1